Consainsights logo
Reports > Life Sciences > Intragastric Balloon Market Report

Intragastric Balloon Market Size, Share, Industry Trends and Forecast to 2033

This report provides an in-depth analysis of the Intragastric Balloon market from 2023 to 2033, including insights on market dynamics, segmentation, regional performance, technological advancements, and future trends.

Metric Value
Study Period 2023 - 2033
2023 Market Size $450.00 Million
CAGR (2023-2033) 6.5%
2033 Market Size $858.74 Million
Top Companies Apollo Endosurgery, ReShape Lifesciences, Spatz Medical, Allergan (AbbVie)
Last Modified Date 15 Nov 2024

Intragastric Balloon Market Report (2023 - 2033)

Intragastric Balloon Market Overview

The Intragastric Balloon industry is marked by continuous innovations and adaptations to meet the rising demand for effective obesity solutions. Manufacturers are focusing on developing balloons that are safer and more comfortable, with advanced materials and effective deployment mechanisms. The industry faces challenges such as regulatory hurdles and competition from alternative bariatric procedures. Nevertheless, the increasing focus on preventive healthcare and weight management is expected to bolster industry growth.

What is the Market Size & CAGR of Intragastric Balloon market in 2023?

In 2023, the global Intragastric Balloon market is estimated to reach USD 510 million. With a projected CAGR of 8.3% from 2023 to 2033, the market is set to grow substantially due to increasing healthcare expenditure, enhanced healthcare infrastructure, and rising prevalence of obesity and related comorbidities. The demand for non-invasive weight loss solutions is expected to drive market growth as more patients opt for intragastric balloons as a preferred method for managing obesity.

Intragastric Balloon Industry Analysis

The Intragastric Balloon industry is marked by continuous innovations and adaptations to meet the rising demand for effective obesity solutions. Manufacturers are focusing on developing balloons that are safer and more comfortable, with advanced materials and effective deployment mechanisms. The industry faces challenges such as regulatory hurdles and competition from alternative bariatric procedures. Nevertheless, the increasing focus on preventive healthcare and weight management is expected to bolster industry growth.

Intragastric Balloon Market Segmentation and Scope

The Intragastric Balloon market is segmented by product type, application, end-user, and distribution channel. The product types include silicone, polyurethane, and gas-filled balloons, each catering to specific patient needs. Applications range from obesity treatment to diabetes management and post-surgery recovery. The end-user segment comprises hospitals, specialty clinics, and medical research centers, indicating a wide spectrum of healthcare providers integrating these solutions into their services. Lastly, distribution channels are categorized into online and offline retailing, showing varied consumer purchasing preferences that impact market dynamics.

Request a custom research report for industry.

Intragastric Balloon Market Analysis Report by Region

Europe Intragastric Balloon Market Report:

The European market is also on the rise, with an expected increase from USD 150.93 million in 2023 to USD 288.02 million by 2033. The growing prevalence of obesity and government initiatives promoting healthy living are significant growth factors.

Asia Pacific Intragastric Balloon Market Report:

In the Asia Pacific region, the Intragastric Balloon market is projected to grow from USD 83.88 million in 2023 to USD 160.07 million by 2033, driven by rising obesity rates and improved healthcare infrastructure.

North America Intragastric Balloon Market Report:

In North America, the market size is expected to grow from USD 155.70 million in 2023 to USD 297.13 million by 2033, supported by high health consciousness, advanced medical technologies, and a large pool of obesity patients seeking non-invasive solutions.

South America Intragastric Balloon Market Report:

The South American market is currently facing challenges, with figures showing a decrease from USD -0.58 million in 2023 to USD -1.12 million in 2033, reflecting the limited access to healthcare facilities and rising costs of intragastric solutions.

Middle East & Africa Intragastric Balloon Market Report:

In the Middle East and Africa, the market is anticipated to rise from USD 60.08 million in 2023 to USD 114.64 million in 2033, as increasing obesity rates combined with improving healthcare facilities drive market adoption.

Request a custom research report for industry.

Intragastric Balloon Market Analysis By Product

Global Intragastric Balloon Market, By Product Type Market Analysis (2023 - 2033)

The Intragastric Balloon market can be segmented based on product types: silicone balloons, polyurethane balloons, and gas-filled balloons. Silicone balloons have the largest market share, expected to remain dominant owing to their effectiveness and patient comfort. Polyurethane balloons are gaining traction due to their durability and enhanced performance. Gas-filled intragastric balloons are also emerging as a viable option for temporary weight loss solutions.

Intragastric Balloon Market Analysis By Application

Global Intragastric Balloon Market, By Application Market Analysis (2023 - 2033)

The application segment of the Intragastric Balloon market includes obesity treatment, diabetes management, and post-surgery recovery. Obesity treatment dominates this category, reflecting the urgent need for effective weight loss solutions. The increasing prevalence of diabetes and the need for effective management strategies utilizing intragastric balloons for weight control continues to emerge as a key trend.

Intragastric Balloon Market Analysis By End User

Global Intragastric Balloon Market, By End User Market Analysis (2023 - 2033)

End users in the intragastric balloon market include hospitals, specialty clinics, and medical research centers. Hospitals constitute the largest share, due to their comprehensive services and access to advanced medical technologies. Specialty clinics are also becoming popular for patients seeking targeted weight loss treatments, while medical research centers contribute to advancements in the technology and techniques used in treatment.

Intragastric Balloon Market Analysis By Region

Global Intragastric Balloon Market, By Region Market Analysis (2023 - 2033)

As discussed in the regional analysis, the competing dynamics emphasize the rising adoption of intragastric balloons across North America and Europe, while other regions are at varying stages of market development.

Intragastric Balloon Market Analysis By Distribution Channel

Global Intragastric Balloon Market, By Distribution Channel Market Analysis (2023 - 2033)

The distribution channels include online and offline retail. Online retail accounts for the largest market share, with an increasing number of patients opting for easier access to solutions. Offline retail remains significant, especially in regions with limited internet connectivity or where personal consultation is highly valued.

Intragastric Balloon Market Trends and Future Forecast

The Intragastric Balloon market is expected to see a surge in demand due to the increasing global prevalence of obesity, proactive healthcare policies, and investment in healthcare technology. The market trends suggest an emphasis on patient comfort, enhanced material technology for balloon formation, and the growing role of telemedicine in patient counseling and follow-ups. Challenges may include regulatory hurdles and competition from alternative weight loss methods. By 2033, the market is expected to continue its growth trajectory, anticipated to reach a market size of approximately USD 1 billion.

Request a custom research report for industry.

Global Market Leaders and Top Companies in Intragastric Balloon Industry

Apollo Endosurgery:

A leading company focused on developing innovative surgical and non-surgical weight loss solutions, including the intragastric balloon technology.

ReShape Lifesciences:

Specializes in non-surgical weight-loss products with a wide array of solutions, including the ReShape intragastric balloon.

Spatz Medical:

Offers unique, adjustable intragastric balloons that provide personalized weight loss options for patients.

Allergan (AbbVie):

A key player in the aesthetic and obesity treatment space, recognized for the ORBERA intragastric balloon.

We're grateful to work with incredible clients.

Datasite
Agilent
Asten Johnson
Bio-Rad
Carl Zeiss
Dywidag
Illumina
LEK Consulting
Shell